881 related articles for article (PubMed ID: 15932436)
21. Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients.
Pape E; Rezvoy N; Penel N; Salleron J; Martinot V; Guerreschi P; Dziwniel V; Darras S; Mirabel X; Mortier L
J Am Acad Dermatol; 2011 Nov; 65(5):983-90. PubMed ID: 21641081
[TBL] [Abstract][Full Text] [Related]
22. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin.
Foote M; Harvey J; Porceddu S; Dickie G; Hewitt S; Colquist S; Zarate D; Poulsen M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):677-84. PubMed ID: 19906498
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
24. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb--a review of 60 cases.
Poulsen M; Round C; Keller J; Tripcony L; Veness M
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):393-7. PubMed ID: 19515508
[TBL] [Abstract][Full Text] [Related]
26. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
27. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
28. Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management.
Veness MJ
Australas J Dermatol; 2006 Aug; 47(3):160-5. PubMed ID: 16866994
[TBL] [Abstract][Full Text] [Related]
29. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
30. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
31. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
32. Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature.
Koh CS; Veness MJ
Australas J Dermatol; 2009 Nov; 50(4):249-56. PubMed ID: 19916967
[TBL] [Abstract][Full Text] [Related]
33. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-based chemotherapy for merkel cell carcinoma of the skin.
Pectasides D; Pectasides M; Psyrri A; Koumarianou A; Xiros N; Pectasides E; Gaglia A; Lianos E; Papaxoinis G; Lampadiari V; Economopoulos T
Cancer Invest; 2006 Dec; 24(8):780-5. PubMed ID: 17162559
[TBL] [Abstract][Full Text] [Related]
35. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
36. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
37. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma.
Boyle F; Pendlebury S; Bell D
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):315-23. PubMed ID: 7836085
[TBL] [Abstract][Full Text] [Related]
38. Management of Merkel tumours: an evidence-based review.
Henness S; Vereecken P
Curr Opin Oncol; 2008 May; 20(3):280-6. PubMed ID: 18391627
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin.
Mojica P; Smith D; Ellenhorn JD
J Clin Oncol; 2007 Mar; 25(9):1043-7. PubMed ID: 17369567
[TBL] [Abstract][Full Text] [Related]
40. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
